ZEISS Ventures invests in life science start-up InSphero to drive 3D cell culture research
Strategic investment is closely linked to ZEISS Research Microscopy Solutions and its capabilities in automated, high-resolution imaging and 3D image analysis
ZEISS is investing in life science start-up InSphero to further advance the adoption of 3D microtissues in research and drug development. InSphero AG, a pioneer in 3D spheroid and cell-based assays in pharmaceutical drug discovery and safety testing, has raised an eight-figure amount in its latest funding round. InSphero will utilize the proceeds to commercialize its cryo-preservation technology to enable further growth and scalability. ZEISS Ventures is participating in the financing round along with internal and external investors.

Press contact:
Jörg Nitschke
Phone: +49 7364 20-3242
Email: joerg.nitschke@zeiss.com